Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Physics and Biophysics, Group Protein X-ray Crystallography and Signal Transduction, Berlin, Germany.
Department of Nephrology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Front Endocrinol (Lausanne). 2022 Apr 19;13:880002. doi: 10.3389/fendo.2022.880002. eCollection 2022.
In conjunction with the endothelin (ET) type A (ETR) and type B (ETR) receptors, angiotensin (AT) type 1 (ATR) and type 2 (ATR) receptors, are peptide-binding class A G-protein-coupled receptors (GPCRs) acting in a physiologically overlapping context. Angiotensin receptors (ATRs) are involved in regulating cell proliferation, as well as cardiovascular, renal, neurological, and endothelial functions. They are important therapeutic targets for several diseases or pathological conditions, such as hypertrophy, vascular inflammation, atherosclerosis, angiogenesis, and cancer. Endothelin receptors (ETRs) are expressed primarily in blood vessels, but also in the central nervous system or epithelial cells. They regulate blood pressure and cardiovascular homeostasis. Pathogenic conditions associated with ETR dysfunctions include cancer and pulmonary hypertension. While both receptor groups are activated by their respective peptide agonists, pathogenic autoantibodies (auto-Abs) can also activate the ATR and ETR accompanied by respective clinical conditions. To date, the exact mechanisms and differences in binding and receptor-activation mediated by auto-Abs as opposed to endogenous ligands are not well understood. Further, several questions regarding signaling regulation in these receptors remain open. In the last decade, several receptor structures in the apo- and ligand-bound states were determined with protein X-ray crystallography using conventional synchrotrons or X-ray Free-Electron Lasers (XFEL). These inactive and active complexes provide detailed information on ligand binding, signal induction or inhibition, as well as signal transduction, which is fundamental for understanding properties of different activity states. They are also supportive in the development of pharmacological strategies against dysfunctions at the receptors or in the associated signaling axis. Here, we summarize current structural information for the ATR, ATR, and ETR to provide an improved molecular understanding.
与内皮素(ET)A型(ETR)和 B 型(ETR)受体一起,血管紧张素(AT)1 型(ATR)和 2 型(ATR)受体是在生理上重叠的情况下起作用的肽结合 A 类 G 蛋白偶联受体(GPCR)。血管紧张素受体(ATRs)参与调节细胞增殖以及心血管、肾脏、神经和内皮功能。它们是几种疾病或病理状况的重要治疗靶点,如肥大、血管炎症、动脉粥样硬化、血管生成和癌症。内皮素受体(ETRs)主要在血管中表达,但也在中枢神经系统或上皮细胞中表达。它们调节血压和心血管稳态。与 ETR 功能障碍相关的致病条件包括癌症和肺动脉高压。虽然这两个受体群都被各自的肽激动剂激活,但致病自身抗体(auto-Abs)也可以激活 ATR 和 ETR,并伴有各自的临床状况。迄今为止,自身抗体与内源性配体相比,在结合和受体激活方面的确切机制和差异尚不清楚。此外,这些受体中信号转导的几个问题仍然存在。在过去的十年中,使用传统同步加速器或 X 射线自由电子激光器(XFEL)的蛋白质 X 射线晶体学确定了 apo 和配体结合状态下的几种受体结构。这些无活性和活性复合物提供了关于配体结合、信号诱导或抑制以及信号转导的详细信息,这对于理解不同活性状态的性质是基本的。它们还有助于开发针对受体或相关信号轴功能障碍的药理学策略。在这里,我们总结了 ATR、ATR 和 ETR 的当前结构信息,以提供更好的分子理解。